Provided by Tiger Trade Technology Pte. Ltd.

ResMed

228.25
-1.1900-0.52%
Pre-market: 229.301.05+0.46%05:42 EDT
Volume:1.07M
Turnover:243.47M
Market Cap:32.93B
PE:21.88
High:229.33
Open:228.19
Low:224.26
Close:229.44
52wk High:284.87
52wk Low:180.27
Shares:144.25M
Float Shares:143.49M
Volume Ratio:0.94
T/O Rate:0.74%
Dividend:2.40
Dividend Rate:1.05%
EPS(TTM):10.43
EPS(LYR):10.43
ROE:24.27%
ROA:14.00%
PB:5.00
PE(LYR):21.88

Loading ...

Resmed to Report Fourth Quarter Fiscal 2026 Results-rmd.n

Reuters
·
Jul 01

Resmed to Report Fiscal Q4 Earnings After NYSE Close

Reuters
·
Jul 01

Resmed to Report Fourth Quarter Fiscal 2026 Earnings on August 6, 2026

THOMSON REUTERS
·
Jul 01

Beware Social Security's Dreaded 'tax Torpedo'

Dow Jones
·
Jun 27

Beware the Social Security 'Tax Torpedo' -- Barrons.com

Dow Jones
·
Jun 24

ResMed Inc. Stock Rises Tuesday, Outperforms Market

Dow Jones
·
Jun 24

ResMed sets BDR dividend at BRL 0.52 per unit, payable June 24

Reuters
·
Jun 23

ResMed Is Maintained at Overweight by Keybanc

Dow Jones
·
Jun 22

KeyBanc Adjusts Price Target on ResMed to $266 From $290, Maintains Overweight Rating

MT Newswires Live
·
Jun 22

ResMed price target lowered to $266 from $290 at KeyBanc

TIPRANKS
·
Jun 22

ResMed Inc. Stock Rises Thursday, Outperforms Market

Dow Jones
·
Jun 19

ResMed Loses Bull as Margin Outlook Moderates -- Market Talk

Dow Jones
·
Jun 18

ResMed Inc. Stock Falls Wednesday, Underperforms Market

Dow Jones
·
Jun 18

ResMed Shares Fall After Morgan Stanley Downgrade

MT Newswires Live
·
Jun 18

ResMed Cut to Equal-Weight From Overweight by Morgan Stanley

Dow Jones
·
Jun 17

Resmed Shares Down 1.2% Premarket After Morgan Stanley Cuts to Equal Weight From Overweight

THOMSON REUTERS
·
Jun 17

Morgan Stanley Downgrades ResMed to Equalweight From Overweight, Adjusts PT to $230 From $286

MT Newswires Live
·
Jun 17

ResMed Inc. Stock Falls Monday, Underperforms Market

Dow Jones
·
Jun 16

ResMed Is Maintained at Buy by Citigroup

Dow Jones
·
Jun 16

Citigroup Adjusts Price Target on ResMed to $270 From $340, Maintains Buy Rating

MT Newswires Live
·
Jun 15